Performance of two SARS-CoV-2 rapid antigen detection tests in resource limited settings, the case of Mali.


Journal

African health sciences
ISSN: 1729-0503
Titre abrégé: Afr Health Sci
Pays: Uganda
ID NLM: 101149451

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 8 7 2024
pubmed: 8 7 2024
entrez: 8 7 2024
Statut: ppublish

Résumé

While real-time reverse transcription PCR (RT-PCR) is the recommended laboratory method to diagnose severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection, its use in resource limited settings can be difficult to maintain due to high testing demand and shortage of reagents. The aim of this study was to evaluate the performances of Realy Tech™ and Standard Q™ in comparison to RT-PCR in a relatively low COVID-19 prevalence setting, Mali. We conducted a cross-sectional study between January and April 2021 in Bamako and Kati regions to evaluate both rapid tests during a large SARS-CoV-2 prevalence study in Mali. Of the 390 samples tested, the sensitivity and specificity of Realy Tech™ and Standard Q™ were 57.1% (95%CI: 44.1-69.2), 95.8% (95%CI: 93.1-97.5); 61.9% (95%CI: 46.8-75.0), and 94.1% (95%CI: 89.5-96.8) respectively. Using RT-PCR, the global prevalence of SARS-CoV-2 was 14.4% (56/390). In both rapid antigen tests, the performance was better when used in suspected patients compared to positive patients under treatment. Moreover, higher viral loads equivalent to Ct < 25 were associated with better detection rates. While waiting for more complete data, these preliminary studies suggest that Realy Tech™ and Standard Q™ should not be used alone for COVID-19 diagnosis in Mali.

Identifiants

pubmed: 38974252
doi: 10.4314/ahs.v23i4.15
pii: jAFHS.v23.i4.pg122
pmc: PMC11225473
doi:

Substances chimiques

Antigens, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-131

Informations de copyright

© 2023 Fatimata D et al.

Déclaration de conflit d'intérêts

The funding sources of this study had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. All authors reported no conflicts.

Auteurs

Diallo Fatimata (D)

University of Sciences Techniques and Technologies of Bamako, University Clinical Research Center (UCRC).

Diarra Bassirou (D)

University of Sciences Techniques and Technologies of Bamako, University Clinical Research Center (UCRC).

Sarro Yeya Dit Sadio (SYD)

University of Sciences Techniques and Technologies of Bamako, University Clinical Research Center (UCRC).

Tolofoudie Mohamed (T)

University of Sciences Techniques and Technologies of Bamako, University Clinical Research Center (UCRC).

Toure Mahamoudou (T)

University of Sciences Techniques and Technologies of Bamako, University Clinical Research Center (UCRC).

Diallo Dramane (D)

University of Sciences Techniques and Technologies of Bamako, University Clinical Research Center (UCRC).

Togo Antieme Congo Georges (TAC)

University of Sciences Techniques and Technologies of Bamako, University Clinical Research Center (UCRC).

Bane Sidy (B)

University of Sciences Techniques and Technologies of Bamako, Laboratory of Virology (LV).

Abdou Mohamed (A)

National Institute of Public Health (INSP), Hippodrome, Bamako, Mali, Laboratory and Biomedical Research.

Konate Mama Sy (KM)

Ministry of Health and Social Development, Bamako, Mali, Health Referral Center Six.

Dicko Abdoul Razakou (DA)

Ministry of Health and Social Development, Bamako, Mali, Health Referral Center Four.

Guindo Ibrehima (G)

National Institute of Public Health (INSP), Hippodrome, Bamako, Mali, Laboratory and Biomedical Research.

Saliba Katy Shaw (SK)

Division of Clinical Research, NIAID/NIH, Bethesda, MD, USA, Collaborative Clinical Research Branch.

Kone Amadou (K)

University of Sciences Techniques and Technologies of Bamako, University Clinical Research Center (UCRC).

Mamadou Diakite (M)

University of Sciences Techniques and Technologies of Bamako, University Clinical Research Center (UCRC).

Doumbia Seydou (D)

University of Sciences Techniques and Technologies of Bamako, University Clinical Research Center (UCRC).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH